NEW YORK, Feb. 18 - Gene-IT over the weekend said that Pfizer has licensed its LASSAP gene sequence-comparing software.
Under terms of the deal, Pfizer scientists will be allowed to use the LASSAP technology for a number of tasks, including mining public and private mammalian genome databases.
Financial terms of the agreement were not disclosed.
Gene-IT, a privately held company based in France, launched LASSAP four years ago. The company has similar deals with Bayer Crop Science/Biogemma, Derwent, BioMerieux, DuPont, Servier Labs, and Organon.
In October 2001, Gene-IT opened a subsidiary in Los Altos, Calif., to help it carve a bigger foothold in the US market.